MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection

Figure 3

Validation of naturally presented MHC peptides from HBV infected cells. Mass spectrometry (MS/MS) spectra of the experimentally identified peptides (top spectra) versus their synthetic analogs (bottom spectra). Fragment masses that match are denoted.